Dec. 18, 2024Free access to BioWorld coronavirus articlesThe articles in this collection are from BioWorld’s ongoing coverage of the COVID-19 coronavirus pandemic. They are available for free with registration. Note that we have added three critical tables, which are continuously updated: Vaccines and therapeutics in development Diagnostics with U.S. FDA emergency use authorization Clinical trials of biopharma products affected by COVID-19
Dec. 13, 2024miR-1-3p levels predict case severity in hospitalized COVID-19 patientsIncreasing evidence shows that circulating microRNAs (miRNAs) regulate biological processes involved in COVID-19 complications.
Dec. 10, 2024miR-1-3p levels predict case severity in hospitalized COVID-19 patientsIncreasing evidence shows that circulating microRNAs (miRNAs) regulate biological processes involved in COVID-19 complications.
